Covid-19 vaccines: safety surveillance manual - Stakeholders
22 December 2020
| Manual
Overview
Vaccine safety monitoring, including effective reporting of adverse events following immunization (AEFIs), investigation and assessment of reported cases and taking necessary actions, requires broad and timely collaboration between national, regional and global stakeholders.
International collaboration will be essential to verify the safety and effectiveness of the many COVID-19 vaccines that will be produced and used in many different countries and administered to large numbers of people in a short period of time. Therefore, mapping national, regional and global stakeholders and their responsibilities is key for ensuring appropriate vaccine safety monitoring of these newly developed vaccines.
.
WHO Team
Pharmacovigilance (PVG),
Regulation and Prequalification (RPQ)
Number of pages
26
Reference numbers
WHO Reference Number: WHO/MHP/RPQ/PVG/2021.11
Copyright
CC BY-NC-SA 3.0 IGO